Cargando…
Hypoxia Supports Differentiation of Terminally Exhausted CD8 T Cells
Hypoxia, angiogenesis, and immunosuppression have been proposed to be interrelated events that fuel tumor progression and impair the clinical effectiveness of anti-tumor therapies. Here we present new mechanistic data highlighting the role of hypoxia in fine-tuning CD8 T cell exhaustion in vitro, in...
Autores principales: | Bannoud, Nadia, Dalotto-Moreno, Tomás, Kindgard, Lucía, García, Pablo A., Blidner, Ada G., Mariño, Karina V., Rabinovich, Gabriel A., Croci, Diego O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137905/ https://www.ncbi.nlm.nih.gov/pubmed/34025660 http://dx.doi.org/10.3389/fimmu.2021.660944 |
Ejemplares similares
-
Tumor Necrosis Factor Receptor-1 (p55) Deficiency Attenuates Tumor Growth and Intratumoral Angiogenesis and Stimulates CD8(+) T Cell Function in Melanoma
por: Rodriguez, Yamila I., et al.
Publicado: (2020) -
Thwarting galectin-induced immunosuppression in breast cancer
por: Salatino, Mariana, et al.
Publicado: (2013) -
Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis: Glycans make the difference
por: Croci, Diego O, et al.
Publicado: (2014) -
Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression
por: Girotti, María Romina, et al.
Publicado: (2019) -
CD39 Expression Identifies Terminally Exhausted CD8(+) T Cells
por: Gupta, Prakash K., et al.
Publicado: (2015)